Geron (GERN) Non-Current Assets (2010 - 2026)

Geron's (GERN) quarterly Non-Current Assets came in at $35.6 million in Q1 2026, down 46.63% year-on-year from $66.7 million in Q1 2025, and down 29.2% quarter-over-quarter from $50.3 million in Q4 2025.

Geron (GERN) Non-Current Assets (2010 - 2026) Analysis & Trends

Geron has disclosed Non-Current Assets across 17 years of filings, most recently posting $35.6 million for Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $35.6 million, down 46.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.5 million (down 38.28% YoY), and the FY2025 annual result was $50.3 million, down 51.09% from the prior year.
  • Non-Current Assets came in at $35.6 million for Q1 2026 at Geron, down from $50.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $102.8 million in Q4 2024 to a low of $10.3 million in Q4 2022.
  • The 5-year median for Non-Current Assets is $45.0 million (2025), against an average of $45.0 million.
  • Across the five-year window, Non-Current Assets tumbled 78.82% in 2022 and soared 639.67% in 2023, its largest moves.
  • Geron's Non-Current Assets stood at $10.3 million in 2022, then surged by 410.49% to $52.7 million in 2023, then surged by 94.94% to $102.8 million in 2024, then slumped by 51.09% to $50.3 million in 2025, then fell by 29.2% to $35.6 million in 2026.
  • The last three Non-Current Assets figures came in at $35.6 million (Q1 2026), $50.3 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Geron 729,618.77 729,618.77 - 35.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.59 Mn
Dec 31, 2025 50.27 Mn
Sep 30, 2025 45.04 Mn
Jun 30, 2025 49.60 Mn
Mar 31, 2025 66.68 Mn
Dec 31, 2024 102.79 Mn
Sep 30, 2024 46.89 Mn
Jun 30, 2024 76.09 Mn
Mar 31, 2024 30.57 Mn
Dec 31, 2023 52.73 Mn
Sep 30, 2023 77.93 Mn
Jun 30, 2023 38.02 Mn
Mar 31, 2023 37.85 Mn
Dec 31, 2022 10.33 Mn
Sep 30, 2022 10.54 Mn
Jun 30, 2022 10.79 Mn
Mar 31, 2022 22.50 Mn
Dec 31, 2021 38.83 Mn
Sep 30, 2021 49.74 Mn
Jun 30, 2021 50.41 Mn